VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TAKTakeda Pharmaceutical Company Limited
$15.91$49.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTAKQuarterly Cash Flow

Takeda Pharmaceutical Company Limited (TAK) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Takeda Pharmaceutical Company Limited (TAK) quarterly cash flow statement — complete operating, investing & financing history

TAK Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23
Cash from Operations19.66B360.04B378.23B215.42B222.16B383.76B280.96B170.3B278.59B146.45B198.91B92.4B
Operating CF Margin %1.76%29.68%33.99%19.47%21.09%33.54%23.89%14.1%26.51%13.18%19.07%8.73%
Operating CF Growth %-91.15%-6.18%34.62%26.49%-20.26%162.04%41.25%84.31%-5.14%-61.28%-9.99%9.69%
Net Income-24.77B105.51B-11.73B124.28B-103.2B23.79B92.05B95.25B-3.02B105.75B-47.97B89.41B
Depreciation & Amortization166.88B194.08B184.98B181.64B189.77B186.96B192.45B192.22B186.74B187.06B182.7B171.5B
Stock-Based Compensation0018.73B16.53B17.63B18.3B015.39B18.19B18.71B18.54B15.44B
Deferred Taxes0039.9B26.35B00041.3B0-44.5B-48.01B45.63B
Other Non-Cash Items102.06B48.94B124.4B-99.67B125.42B85.58B76.92B-93.66B-13.18B45.45B92.06B-78.63B
Working Capital Changes-224.52B11.51B21.94B-33.7B-7.46B69.13B-80.45B-80.19B89.86B-166.02B1.59B-150.95B
Change in Receivables-103.74B-12.34B-9.8B48.08B-13.85B12.67B-10.04B-47.74B73.9B14.29B17.29B-90.37B
Change in Inventory21.81B-39.54B-28.96B-13.07B-4.99B21.24B-41.14B-10.08B12.75B-50.55B-49.35B-28.59B
Change in Payables5.27B3.71B0000376M-37.45B070.27B-15.02B-9.4B
Cash from Investing-58.42B-247.98B-48.13B-33.19B-19.68B-115.56B-75.13B-156.69B-61.48B-75.27B-60.58B-266.53B
Capital Expenditures-57.97B-231.04B-40.09B-47.91B-48.79B-45.09B-60.67B-137.8B-64.33B-77.12B-70.04B-269.24B
CapEx % of Revenue5.2%19.04%3.6%4.33%4.63%3.94%5.16%11.41%6.12%6.94%6.71%25.43%
Acquisitions-402.43M2.7B417M29.29B005.42B2.95B-13.7B-26.25B-7M372M
Investments------------
Other Investing-1.04B-5.56B-9.79B-15.48B29.11B-70.47B-27.63B-14.18B11.66B30.11B10.97B2.47B
Cash from Financing-31.72B-169.51B-11.98B-214.9B-301.79B-655.97B-110.05B316.38B-58.22B-97.76B-140.66B-57.78B
Debt Issued (Net)-17.38B-1.14B36.55B22M-547.99B-470.88B230.45B429.61B-11.28B-96.51B-157.07B99.37B
Equity Issued (Net)1.32B975.88M1.51M-51.6B-49.98B00-1.88B000-2.33B
Dividends Paid-1.53B-155.42B-8.79B-145.29B-9.74B-145.45B-9.2B-138.11B-9.13B-138.25B-9.06B-130.75B
Share Repurchases1.32B975.88M1.51M-51.6B-49.98B00-1.88B000-2.33B
Other Financing-14.14B-13.93B-39.75B-18.02B305.92B-39.64B-331.3B26.76B-37.82B137B25.48B-24.07B
Net Change in Cash-69.98B-68.4B331.48B-35.1B-109.01B-364.89B54B347.21B169.44B-29.69B1.67B-217.15B
Free Cash Flow-26.01B317.47B325.4B140.35B173.37B338.67B231.49B112.86B234.05B69.33B128.86B-176.84B
FCF Margin %-2.33%26.17%29.24%12.68%16.46%29.6%19.68%9.34%22.27%6.24%12.35%-16.7%
FCF Growth %-115%-6.26%40.57%24.36%-25.93%388.51%79.64%163.82%255.63%-78.84%-28.56%-1151.06%
FCF per Share-8.3299.06103.1444.1954.81106.8471.8935.5174.6121.8741.16-56.50
FCF Conversion (FCF/Net Income)-0.79x3.41x-32.05x1.73x-2.15x16.13x3.05x1.79x-92.31x1.39x-4.14x1.03x
Interest Paid000034.88B35.81B000000
Taxes Paid000000000000